lung-tumors.ppt

3,126 views 52 slides Jan 30, 2024
Slide 1
Slide 1 of 52
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52

About This Presentation

lung tumor


Slide Content

LUNG TUMORS
Dr. V.Shanthi,
Associate Professor, Department of Pathology
Sri Venkateswara Institute Of Medical Sciences

LUNG TUMORS
Out of many benign and malignant tumors in the lung the vast
majority are –
90 –95% -Carcinomas
5% -Bronchial carcinoids
2 –5 % -Mesenchymal & other neoplasms

CARCINOMA-LUNG
•Most common cause of cancer mortality worldwide
•Age :40-70 yrs with peak incidence in 50s and 60s
•2% of cases appear before the age of 40 years
•Males > Females
•Since 1990 lung cancer mortality in men has reduced but in women it has
not changed because of lagging behind in changing patterns of smoking
•Due to which cancer mortality in women is more due to lung cancer than
breast cancer.

CARCINOMA LUNG -ETIOPATHOGENESIS
Tobacco smoking
•87 % of lung cancers occur in active smokers
•Linear correlation between -Amount of daily smoking
•Duration of the smoking habit
•Average smokers –10 foldrisk
•Heavy smokers (2 packs/ day)–60 fold risk
•Most common: Squamous & Small cell Ca >98%

CARCINOMA LUNG -ETIOPATHOGENESIS
Tobacco smoking
Cessation of smoking decreases the risk of cancer but never returns to
base line
Passive smoking increases the risk for lung cancer –twicethat of non-
cancer
Women have higher susceptibility to tobacco carcinogens than men
Smoking by cigars and pipes also increases the risk but less than that of
cigarette smoking
Smokeless tobacco is not safe substitute for cigarette smoking, as they
spare lungs but cause oral cancers and lead to nicotine addiction

CARCINOMA LUNG -ETIOPATHOGENESIS
Tobacco smoking
•More than 1200 substances are present in cigarette smoke, many of
which are potential carcinogens
•Initiators : Polycyclic aromatic hydrocarbons (Benzopyrene)
•Promotors : Phenol derivatives, Radio active elements (Carbon-14,
pot.40), Arsenic, nickel, molds etc

CARCINOMA LUNG -ETIOPATHOGENESIS
Industrial Hazards
Industrial exposures such as asbestos, arsenic, chromium, uranium, nickle,
vinyl chloride and mustard gas increases risk of lung cancer
High-dose ionizing radiation is carcinogenic
Uranium coupled with smoking –10 times
Asbestos coupled with smoking –50 times 
Asbestos workers with out smoking –5 folds increased risk

CARCINOMA LUNG -ETIOPATHOGENESIS
Air-Pollution
Adds to risk who smoke or non smokers exposed to second
hand smoke
Chronic exposure to air particulates in smog causes lung
irritation, chronic inflammation and repair which increases risk
for cancers
Radon-a ubiquitous radioactive gas attach to environmental
aerosols inhalation & Bronchial deposition

CARCINOMA LUNG -ETIOPATHOGENESIS
Dietary factors:
Vit-A deficiency if associated with smoking risk
Chronic scarring :
Adeno Carcinoma occurs in areas of chronic scarring
Eg: Old TB, Chronic interstitial fibrosis, Asbestosis, old infarcts,
Scleroderma

CARCINOMA LUNG -ETIOPATHOGENESIS
All the smokers do not develop lung cancer due to modified mutagenic
effect of carcinogens in smoke by genetic variants (11% of heavy
smokers develop lung cancers)
For example –many chemical carcinogens are converted to active
carcinogens via activation through highly polymorphic p-450
monooxygenase enzyme system.
Specific p-450 polymorphisms have an increased capacity to activate
procarcinogens in cigarette smoke, and smokers with this genetic
variant have increased risk

CARCINOMA LUNG –MOLECULAR GENETICS
10 to 20 genetic mutations occur by the time tumor is clinically
apparent
Dominant oncogenes : C-Myc, K-RAS
Commonly deleted / inactivated tumor suppressor genes : p53, RB,
p16 ch.3p
p53 mutations : Both small & non-small cell carcinomas

MOLECULAR PATHOGENESIS OF LUNG
CANCER
SQUAMOUS CELL CARCINOMA SMALL CELL CARCINOMA
ADENOCARCINOMA
LUNG CANCER IN NON-SMOKERS
•ASSOCIATED WITH SMOKING
•CHROMOSOMAL DELETION –3p, 9p (site of CDKN2A gene) and
17p (Site of TP53 gene)
•LOSS OF EXPRESSION of Rbtumor suppressor gene
•AMPLIFICATIONof FGFR1
•INACTIVATIONof cyclin dependent kinase inhibitor gene –p16
protein lost
•STRONGLY ASSOCIATED WITH SMOKING
•LOSS OF FUNCTION ABERRATIONS involving
TP53 and Rbgene
•Chromosome 3p deletions
•AMPLIFICATION of genes of Mycfamily
•GAIN OF FUNCTION MUTATIONS involving multiple
genes encoding tyrosine kinase receptors –EGFR,
ALK, ROS, MET and RET
•MUTATIONS in the KRAS gene in tumors without
tyrosine kinasegene
•More common in females and are
adenocarcinomas
•Common mutations –EGFR
•TP 53 mutations –not uncommon
INHERITED PREDISPOSITION
•Rare –found in Li-Fraumenisyndrome who inherit p53 mutations
•First degree relatives –2-3 folds increased risk

ETIOLOGICAL FACTORS
TOBACCO SMOKING
INDUSTRIAL HAZARDS
•ASBESTOS
•ARSENIC
•CHROMIUM
•URANIUM
•NICKLE
•VINYL CHLORIDE
•MUSTARD GAS
AIR POLLUTION
•AIR PARTICULATES
•RADON
DIETARY FACTORS
VIT A DEFICIENCY
CHRONIC SCARRING
•OLD TB, CHRONIC INTERSTITIAL
FIBROSIS, OLD INFARCT
•ADENOCARCINOMA
MOLECULAR GENETIC
ABERRATIONS

CARCINOMA LUNG
Etiopathogenesis
•Arises by stepwise accumulation of genetic abnormalities
•Bronchial epithelium Neoplastic tissue
•Normal mucosa Basal cell Hyperplasia squamous
Metaplasia Dysplasia Ca. insitu Invasive carcinoma

PULMONARY CARCINOGENESIS

CARCINOMA LUNG
HISTOLOGIC CLASSIFICATION
Adenocarcinoma (38%)
Minimally invasive adenocarcinoma (mucinous, non-mucinous)
Invasive adenocarcinoma -Lepidic, acinar, papillary , and solid
patterns
Mucinous adenocarcinoma
Squamous cell Carcinoma (20%)
Papillary, clear cell, small cell, basaloid
Small cell Carcinoma (14%) -combined small cell carcinoma
Large cell carcinoma (3%)–Large cell neuroendocrine carcinoma

CARCINOMA LUNG
HISTOLOGIC CLASSIFICATION
Others (25%)
Adenosquamouscarcinoma
Carcinoid tumors (Typical, Atypical)
Carcinomas with pleomorphic, sarcomatoidor sarcomatous
elements
Carcinomas of Salivary gland type
Unclassified carcinoma

CARCINOMA LUNG
Four types of precursor epithelial lesions are
Squamous dysplasia and carcinoma in-situ
Atypical adenomatous hyperplasia
Adenocarcinoma in-situ
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

BRONCHOGENIC CARCINOMA
MORPHOLOGY
Arises most often in & about the hilus of lung
Adenocarcinoma –peripheral lung
Squamous cell carcinoma –central hilar region

SQUAMOUSCELLCARCINOMA
Most common in men
Strongest relationship with smoking
Initially starts as squamous metaplasia or dysplasia in bronchial
epithelium transforming into carcinoma in-situ
During this phase dysplastic epithelial cells are seen in sputum
or bronchial washings though not visible radiologically

SQUAMOUSCELLCARCINOMA
Squamous cell Ca. begins as thickening of bronchial mucosa warty
excrescenceFungate into bronchial lumen intra luminal mass
Penetrate the wall of bronchus infiltrate the peribronchial tissue
(Carina/ mediastinum) Cauliflower like intraparenchymal mass
Bronchial obstruction later leads to distal atelectasis and infection
Grossly –tumor is gray-white, firm to hard with areas of necrosis and
hemorrhage

SQUAMOUS CELLCARCINOMA

SQUAMOUS CELLCARCINOMA

SQUAMOUS CELLCARCINOMA
Microscopically:
Characterized by
Squamous pearls
Individual cell keratinization -cells with dense eosinophilic
cytoplasm
Intercellular bridges
Well differentiated –extensive keratinization with keratin pearls
Moderately differentiated–not extensive differentiation
Poorly differentiated–differentiation is focally seen

SQUAMOUS CELL CARCINOMA

SQUAMOUS CELL CARCINOMA

SQUAMOUS CELL CARCINOMA

ADENOCARCINOMA
Most common in women & non smokers (>75 % found in smokers)
More peripherally located & smaller lesions
Morphological types
Atypical adenomatous hyperplasia –precursor lesion
Adenocarcinoma in-situ –precursor lesion
Microinvasive adenocarcinoma
Adenocarcinoma

ATYPICAL ADENOMATOUS HYPERPLASIA
Small lesion –less than or equal to 5mm
Characterised by dysplastic pneumocytes lining alveolar walls
that are widely fibrotic
Can be single or multiple and can be in lung adjacent to invasive
tumor

ATYPICAL ADENOMATOUS HYPERPLASIA

ATYPICAL ADENOMATOUS HYPERPLASIA

ADENOCARCINOMA IN -SITU
Formerly called as Bronchioloalveolar carcinoma
Lesion less than 3cm
Composed of dysplastic cells growing along pre-existing alveolar
septae
Cells are more dysplastic than atypical adenomatous
hyperplasia and may or may not have intracellular mucin
(Mucinous or non-mucinous respectively)

ADENOCARCINOMA IN -SITU

ADENOCARCINOMA IN-SITU

MICROINVASIVE ADENOCARCINOMA
Tumors with less than 3cms with a small invasive component
(less than 5mm) and peripheral lepidic growth pattern i,e.
tumor cells crawl along the normal alveolar septae
This has far better prognosis when compared to invasive
carcinomas of size larger

ADENOCARCINOMA
Invasive malignant epithelial tumor with glandular differentiation or
mucin production by tumor cells
Lesions are peripherallylocated and are smaller
Present as solitary or multiple nodules
Various histological patterns include –acinar, lepidic, papillary,
micropapillary and solid with mucin formation
At the periphery of the lesion tumor shows lepidic pattern of spread

ADENOCARCINOMA
Non mucinous: cuboidal / low colummar
Mucinous: Tall, Columnar cells with cytoplasmic & intra-
alveolar mucin, growing along alveolar septa
Tumor cells express Thyroid transcription factor –1 (normally
identified in thyroid cells) and is required for normal lung
development

ADENOCARCINOMA

ADENOCARCINOMA

ADENOCARCINOMA

ADENOCARCINOMA

ADENOCARCINOMA

SMALLCELLCARCINOMA
Strongest association with smoking
Highly malignant tumor
Localization –either in central bronchi or in periphery
There is no preinvasive phase
More aggressive widely metastasize and always prove fatal

SMALLCELLCARCINOMA
Microscopy
Small cells with scant cytoplasm, finely granular nuclear chromatin (salt
& pepper pattern),ill defined cell borders and absent or inconspicuous
nucleoli
Cells are round to oval showing nuclear moulding
Size of the cell –smaller than 3 times the diameter of small lymphocytes
Cells grow in clusters without glandular and squamous differentiation
Azzopardi effect –basophilic staining of vessel wall due to encrustation
by DNA of necrotic tumor cells
Necrosis is common
Electron Microscopy: Dense-core neurosecretory granules

SCC -Arising centrally in this lung and spreading extensively

Small cell
Carcinoma
SMALLCELLCARCINOMA

Small cell
Carcinoma
SMALLCELLCARCINOMA
NUCLEARMOULDING

SMALLCELLCARCINOMA
AZZOPARDIEFFECT

LARGECELLCARCINOMA
Undifferentiated malignant epithelial tumor lacking cytologicfeatures
of both squamous or adenocarcinoma
Common in men / smokers
Large nuclei, prominent nucleoli
Variant –large cell neuroendocrine carcinoma
It is a diagnosis of exclusion as it neither expresses markers of
adenocarcinoma (TTF-1, napsinA) and squamous cell carcinoma (p63,
p40)

LARGECELLCARCINOMA

More important in the life is not your
standard of living but living a life with
correct standards
THANK YOU
Tags